Page last updated: 2024-11-06

isonixin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

isonixin: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68767
CHEMBL ID2105035
CHEBI ID134986
SCHEMBL ID24519
MeSH IDM0064467

Synonyms (39)

Synonym
nixyn
isonixin [inn]
isonixinum [inn-latin]
3-pyridinecarboxamide, 1,2-dihydro-2-oxo-n-(2,6-xylyl)-
einecs 260-521-6
isonixine
isonixin
2,6-xylidide of 2-pyridone-3-carboxylic acid
1,2-dihydroxy-2-oxo-n-(2,6-xylyl)-3-pyridinecarboxamide
isonixine [inn-french]
nixyn hermes
n-(2,6-dimethylphenyl)-1,2-dihydro-2-oxo-3-pyridinecarboxamide
isonixina [inn-spanish]
2-hydroxy-2',6'-nicotinoxylidide
2,6-xylidid der 2-pyridon-3-carboxylsaure [german]
3-pyridinecarboxamide, n-(2,6-dimethylphenyl)-1,2-dihydro-2-oxo-
CHEBI:134986
n-(2,6-dimethylphenyl)-2-oxo-1h-pyridine-3-carboxamide
57021-61-1
D08089
nixyn hermes (tn)
isonixin (inn)
byx6e7m5qe ,
isonixinum
2,6-xylidid der 2-pyridon-3-carboxylsaure
isonixina
unii-byx6e7m5qe
CHEMBL2105035
isonixin [mart.]
isonixin [mi]
isonixin [who-dd]
SCHEMBL24519
AKOS027597705
AKOS027475368
Q3803297
n-(2,6-dimethylphenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
DTXSID80877494
CS-0026275
HY-105579
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic amideAn amide in which the amide linkage is bonded directly to an aromatic system.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (88.89)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (27.27%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (9.09%)4.05%
Observational0 (0.00%)0.25%
Other7 (63.64%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]